SCHEMBL584524

SCHEMBL584524

CCCCC(=O)CC(=O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.59
HDAC3 O15379 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC2 Q92769 1/20 0.57
NCOR2 Q9Y618 1/20 0.57
MAOB P27338 1/20 0.57
RAB9A P51151 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MAPT P10636 2/20 0.56
ALDH1A1 P00352 1/20 0.56
GAA P10253 1/20 0.56
HTT P42858 1/20 0.56
NR4A1 P22736 1/20 0.56
NR4A2 P43354 1/20 0.56
NR4A3 Q92570 1/20 0.56
PARP10 Q53GL7 1/20 0.54
PLA2G4B P0C869 1/20 0.53
SRD5A2 P31213 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NPC1 O15118 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8473200 0.88 NR4A1 (0.57) EGFRMAOBRAB9ASMN1; SMN2MAPT
SCHEMBL18286487 0.84 MMP1 (0.64) SMN1; SMN2MAPTALDH1A1PLA2G4BL3MBTL1
SCHEMBL4152328 0.83 EGFR (0.72) EGFRHDAC3HDAC1HDAC2NCOR2
SCHEMBL28292838 0.83 NPC1 (0.66) RAB9AMAPTALDH1A1PARP10PLA2G4B
SCHEMBL2348514 0.82 ALOX5 (0.60) HDAC3HDAC1HDAC2NCOR2MAOB
SCHEMBL6602564 0.81 CES1 (0.58) HDAC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL8008103 0.81 FFAR1 (0.67) MAOBL3MBTL1
SCHEMBL11135332 0.81 MMP1 (0.59) SMN1; SMN2MAPTALDH1A1PLA2G4BL3MBTL1
SCHEMBL12987281 0.80 MAOB (0.71) EGFRHDAC3HDAC1HDAC2NCOR2
SCHEMBL9261139 0.80 FFAR1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2636670-B1 Process for preparing benzofurans CAMBREX KARLSKOGA AB (SE) 2016-06-01 EP disclosed
EP-2417099-B1 NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS CAMBREX KARLSKOGA AB (SE) 2015-12-23 EP disclosed
EP-2388256-B1 Process for preparing benzofurans CAMBREX KARLSKOGA AB (SE) 2015-11-25 EP disclosed
US-20140206761-A1 PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS CAMBREX KARLSKOGA AB (SE) 2014-07-24 US disclosed
US-8779201-B2 Process for preparing benzofurans CAMBREX KARLSKOGA AB (SE) 2014-07-15 US disclosed
US-20130338398-A1 Process for Preparing Benzofurans CAMBREX KARLSKOGA AB (SE) 2013-12-19 US disclosed
EP-2636670-A1 Process for preparing benzofurans Cambrex Karlskoga AB (SE) 2013-09-11 EP disclosed
US-8519165-B2 Process for preparing benzofurans CAMBREX KARLSKOGA AB (SE) 2013-08-27 US disclosed
EP-2200993-B1 PROCESS FOR PREPARING BENZOFURANS CAMBREX KARLSKOGA AB (SE) 2012-08-29 EP disclosed
US-20120122971-A1 NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS CAMBREX KARLSKOGA AB (SE) 2012-05-17 US disclosed
EP-2417099-A1 NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS Cambrex Karlskoga AB (SE) 2012-02-15 EP disclosed
EP-2388256-A1 Process for preparing benzofurans Cambrex Karlskoga AB (SE) 2011-11-23 EP disclosed
US-20100292319-A1 PROCESS FOR PREPARING BENZOFURANS CAMBREX KARLSKOGA AB (SE) 2010-11-18 US disclosed
WO-2010116140-A1 NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS CAMBREX KARLSKOGA AB (SE) 2010-10-14 WO disclosed
EP-2200993-A2 PROCESS FOR PREPARING BENZOFURANS Cambrex Karlskoga AB (SE) 2010-06-30 EP disclosed
WO-2009044143-A2 PROCESS FOR PREPARING BENZOFURANS CAMBREX KARLSKOGA AB (SE) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338398-A1 Process for Preparing Benzofurans CYP2F1, CYP4X1, CYP3A4 EGFR 4343/4885HDAC3 2352/4885HDAC1 2793/4885
US-20140206761-A1 PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS CYP3A4, CYP1A2, CYP2D6 EGFR 4471/4885HDAC3 2732/4885HDAC1 3266/4885
US-20120122971-A1 NEW PROCESS FOR PREPARING HYDROXYLAMINES AND MEDICAMENTS CYP3A4, CYP1A2, CYP4B1 EGFR 4435/4885HDAC3 2534/4885HDAC1 3154/4885
US-20100292319-A1 PROCESS FOR PREPARING BENZOFURANS CYP2F1, CYP3A4, CYP4F3 EGFR 4387/4885HDAC3 2124/4885HDAC1 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.